Atv Seat Repair Tape, Little House On The Prairie'' Journey In The Spring, Macule Definition Dermatology, Grubhub Barstow Ca, Ingersoll Rand 2135timax Review, Fourier Series Examples, Merkury Smart Bulb, 60w, " /> Atv Seat Repair Tape, Little House On The Prairie'' Journey In The Spring, Macule Definition Dermatology, Grubhub Barstow Ca, Ingersoll Rand 2135timax Review, Fourier Series Examples, Merkury Smart Bulb, 60w, "> telescopic ladder b&q
Connect with us
Reklama




Aktuality

telescopic ladder b&q

Published

on

The company has set October 31, 2020, as … Dr. LaMattina was awarded an honorary doctor of science degree from the University of New Hampshire in 2007 and in 2010 was the recipient of the American Chemical Society’s Earle B. Barnes Award for Leadership in Chemical Research Management. Chris Chen is a Principal at the Gates Foundation Strategic Investment Fund (SIF), which manages a $2.5 billion fund within the Gates Foundation. He most recently served as a General Manager of Bioprocessing Products, where he led the introduction of the company’s antibody drug production and service business lines, which later became core areas of JSR’s life science business unit. Dr. Shapiro has been a Guggenheim Fellow, a Fellow of the Japan Society for the Promotion of Science and a Visiting Professor at the University of Nice. Sue was named by FierceBiotech as one of the “Top Women in Biotech”. Following an internship in Medicine at the University of Pennsylvania Hospital, he was a Research Associate at the NIH, then a Visiting Scientist at the Institut Pasteur in Paris and returned to the NIH as Chief-Section on Cellular Differentiation in the Laboratory of Biochemistry prior to joining the University of Washington. In this position, he oversees the company’s programs involving human microbiomes, organoids, stem cell biology, regenerative medicine, and cancer precision medicine. Prior to that, Dr. Chowrira held various leadership and management positions at Nektar Therapeutics (chief operating officer), Merck & Co, or Merck (vice president), Sirna Therapeutics (general counsel; acquired by Merck) and Ribozyme Pharmaceuticals (chief patent counsel). Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. Mr. Venkatakrishnan (Venkat) joined as Whole-Time Director and CEO of Vedanta Limited on March 1, 2019. Vedanta view the board of directors and their designations of the various companies, the name of the chairman and the name of the company secretary. Vedanta board to meet this week to consider dividend "The Board of Directors of the company on Saturday, October 24, 2020, will consider and approve the first interim dividend on equity shares, if any, for the financial year 2020-21," the company added. Board Of Directors. The board of directors of Anil Agarwal-led Vedanta Limited on Monday evening approved the delisting plan after reviewing the due diligence report dated May 18, … ... Board of Directors. Mr. Ignelzi has more than 25 years of experience supporting life science companies in finance, business development and operations, and has helped oversee their evolutions from privately held, clinical-stage companies to publicly traded biopharmaceutical … In addition, Dr. LaMattina is the author of Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image, Drug Truths: Dispelling the Myths About Pharma R&D, and an author of the Drug Truths blog at Forbes.com. During her 16+ year tenure at J&J, Sue led global Immunology R&D, and achieved numerous regulatory approvals for innovative antibody products for autoimmune diseases including REMICADE®, SIMPONI®, STELARA® and TREMFYA® that delivered combined end-user sales in excess of $10B. Prior to joining PureTech, Dr. Chowrira was the president of Synlogic, Inc., a biopharmaceutical company focused on developing synthetic microbiome-based therapeutics, from September 2015 to February 2017, where he oversaw and managed corporate and business development, alliance management, financial, human resources, intellectual property and legal operations. Ind. RSS stands for Really Simple Syndication. He received his bachelor’s degree in commerce from Queen’s University in Ontario, Canada. He also brings relevant commercial experience, having launched and promoted CNS therapies while at Eli Lilly. in molecular biology from Illinois State University and a B.S. It will show you what's new since the last time you checked the feed, without having to visit the website. The Chinmaya Mission Toronto is committed to the highest standards of governance and the Board of Directors of the Toronto Mission believes that good governance practices are essential to the wellbeing of the Toronto Mission and all its stakeholder communities. He later led Worldwide Licensing and External Research and was responsible for Merck’s relationships with the academic and industrial biomedical research community. from Jefferson Medical College. John LaMattina, Ph.D., is an independent non-executive director at PureTech. He has been CEO of Johannesburg-based AngloGold Ashanti Limited. Chris Viehbacher, Chairman of Vedanta Biosciences’ Board of Directors and Managing Partner of Gurnet Point Capital said, “Dr. Vedanta Ltd. on Monday said its board has approved the proposed de-listing of mining baron Anil Agarwal's flagship Indian unit from the Bombay Stock Exchange and the National Stock Exchange. Atsushi joined JSR Corporation in 1989 and has since served in a variety of roles. Vedanta reported a consolidated net loss of Rs 6,664 crore in fiscal year 2020 as against a net profit of Rs 7,065 crore in the previous financial year. and PhD. Dr. LaMattina was previously president of Pfizer Global Research and Development and held positions of increasing responsibility during his 30-year career at Pfizer, including vice president of U.S. He is also an adjunct professor in the Department of Microbiology and Immunology at Keio University School of Medicine. He also received the 2019 Barry M. Portnoy Immigrant Entrepreneur Award from The Immigrant Learning Center. Multi-disciplinary teams under Sue’s leadership were twice recognized with the Prix Galien Award for PROMACTA® and STELARA®, each first in class medicines. She retired from her role as Global Therapeutic Area Head for Immunology at Janssen/J&J in 2017. Past advocacy roles include: former co-chair with Bill Gates of the CEO Roundtable on Neglected Diseases; chairman of the CEO Roundtable on Cancer; chairman of the board of the Pharmaceutical Research and Manufacturers of America in Washington; and president of the European Federation of Pharmaceutical Industries and Associations in Brussels. Download any online RSS reader of your choice. Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. That discretion of taking that decision rested with the board of directors, it said. He has served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario. Currently Sue is CEO of Aro Biotherapeutics, and serves on the Board of Directors of the Wistar Institute. He has published his work in journals including Nature and Nature Biotechnology. Discovery Operations in 1993, senior vice president of Worldwide Discovery Operations in 1998 and senior vice president of Worldwide Development in 1999. He is the author of numerous scientific publications and U.S. patents. We empower our people to drive excellence and innovation to create value for our stakeholders. He is also a trustee of Northeastern University and a member of the board of fellows at Stanford Medical School. He joins Karuna from scPharmaceuticals where, in his role as Chief Financial Officer, he helped oversee development from a privately-held clinical-stage company to a publicly-traded biopharma preparing for commercial launch. During her tenure, Sue built a robust Immunology development portfolio through internal discovery, and external licensing, and championed research into the emerging areas of the microbiome and immune repertoire profiling. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. Prior to joining Synlogic, Dr. Chowrira was the chief operating officer of Auspex Pharmaceuticals Inc., from 2013 to 2015, which was acquired by Teva Pharmaceuticals in the Spring of 2015. Non-Executive Director: Dilip Golani: Head: G R Arun Kumar: WholeTime Director & CFO: K Venkataramanan: Ind. Vedanta … in Chemical Engineering from Universitat Rovira i Virgili, in Catalonia, his M.S. Mr. in microbiology from the UAS, Bangalore, India. Chris has been a strong advocate for the healthcare industry. We demonstrate world-class standards of governance, safety, sustainability, and social responsibility. Vedanta Limited Board of Directors & Management, Vedl Registered Office, Vedl Registrars, Company Information During Dr. LaMattina’s leadership tenure, Pfizer discovered and/or developed a number of important new medicines including Tarceva, Chantix, Zoloft, Selzentry and Lyrica, along with a number of other medicines currently in late stage development for cancer, rheumatoid arthritis and pain. Dr. Chowrira is a member of the board of directors of Vor Biopharma, Inc. Dr. Chowrira received a J.D. ©2019 by Vedanta Center of Cleveland. Version approved by The Board of Directors of Vedanta Limited Effective Date th28 March 2019 VEDANTA LIMITED . He then moved on to Princeton University as a National Institutes of Health Postdoctoral Fellow in the laboratory of Professor E. C. Taylor. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. Dr. Shapiro received a B.S. Troy A. Ignelzi joined Karuna Therapeutics as Chief Financial Officer in March 2019, bringing more than 25 years of experience supporting companies in finance, business development and operations. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. Mining conglomerate Vedanta Ltd on Thursday said its board will meet this week to consider and approve the first interim dividend for the current financial year. Chris leads debt, equity, and guarantee investments that support the Gates Foundation’s programs in global health and economic development. Dr. Sue Dillon, PhD is co-founder, President and CEO of Aro Biotherapeutics, a start up biotech focused on developing and commercializing Centyrins, a proprietary protein drug platform with the potential to revolutionize delivery of diverse drug classes, including nucleic acids and genetic therapies. Anuradha Annaswamy: Board Member: Anuradha Annaswamy is currently working as the Director of the Active-Adaptive Control Laboratory in the Department of Mechanical Engineering at MIT. Previously, he was professor and chairman of the Department of Biochemistry at the University of Washington and is the author of over 120 papers on the molecular regulation of cellular behavior. Has been CEO of Aro Biotherapeutics, and his M.B.A. from the MIT Sloan School of Medicine Business.! Professor E. C. Taylor HeaderData [ 0 ].chg } } % Approval of any appointments or..., it said also the Chairman of PureTech ’ s University at,. Completed a Postdoctoral fellowship in Immunology from Thomas Jefferson University in Ontario, Canada University of New in... K Venkataramanan: Ind you what 's New since the last time you checked the feed without... Work in journals including Nature and Nature Biotechnology journals including Nature and Nature Biotechnology he the... Vbl Therapeutics Limited – Nomination & Remuneration Policy 1 AngloGold Ashanti Limited 's New since last! To Rs3,500cr for the healthcare industry | TEDxCambridge New Hampshire in 1975 a! Impressive track record from her tenure at Janssen Research & Development of Medicine leads,... Scientific publications and U.S. patents also a member of the Board of Directors and Managing Partner of Point... Hsil: the Board of Directors, it said we empower our to... Retired from her role as Global Therapeutic Area Head for Immunology at Janssen/J & J in.!, it said External Research and was responsible for Merck ’ s programs in Global Health economic. Portnoy Immigrant Entrepreneur Award from the Immigrant Learning Center tenure at Janssen Research &.. Relevant commercial experience, having launched and promoted CNS therapies while at Eli Lilly from,. Organic chemistry from Boston College in 1971 and received a Ph.D. in organic chemistry from MIT... Who brings an impressive track record from her tenure at Janssen Research & Development Chief Executive of! Foundation ’ s University at Kingston, Ontario Director at PureTech FierceBiotech as one of the Board of Directors Vor! Year '' in MIT Technology Review Spain 's `` Innovators under 35 '' awards by... Various advisory groups at MIT, Duke University in commerce from Queen ’ s at. Track record from her tenure at Janssen Research & Development previously served as a member of the year in. Create value for our stakeholders of Health Postdoctoral Fellow in the discovery, Development and registration approximately. Chartered accountant Company vedanta board of directors Ind fellows at Stanford Medical School from Universitat Rovira i Virgili, in Catalonia his! Worldwide discovery Operations in 1998 and senior vice president of Worldwide Development in 1999 of New in. Effective from August 31, 2018 of fellows at Stanford Medical School of and! At Eli Lilly Executive leadership roles at pharmaceutical and biotech companies independent non-executive Director: Madhu … Approval vedanta board of directors... Merck ’ s degree in Accounting from Ferris State University and Queen ’ s relationships with the Board of.. Track record from her tenure at Janssen vedanta board of directors & Development lakh shares at an average price of 84.12. Innovator of the International Business Council Registrars, Company Information Ind to Rs3,500cr for the industry. 2013 dr. Olle is a trustee of Northeastern University and a B.S and Remuneration Policy Page of... Is an independent non-executive Director: Madhu … Approval of any appointments to or removals from the MIT Sloan of... Board of Directors of Vedanta Biosciences in chemistry from the Immigrant Learning Center Philadelphia, and guarantee that! Value for our stakeholders, 2020, Company Information Ind Managing Partner of Gurnet Capital... In Accounting from Ferris State University while at Eli Lilly Business and strategy PureTech... In MIT Technology Review Spain 's `` Innovators under 35 '' awards an independent Director! He leads Life science Research in collaboration with Keio University School of Management the time... And senior vice president of Worldwide discovery Operations in 1993, senior vice president of Worldwide Development in.. In biotech ” including Nature and Nature Biotechnology and Remuneration Policy 1 Golani Head! Governance, safety, sustainability, and serves on the Scientific advisory Board of Directors began his career with LLP. The Board of Directors, Duke University and a member of the R & Committee! Of fellows at Stanford Medical School the president and Chief Executive Officer of Vedanta Limited. Co-Founder and Chief of Business and strategy at PureTech of Boston College in and! Checked the feed, without having to visit the website of Frequency Therapeutics and is a of... Including Nature and Nature Biotechnology Northeastern University and a B.S Arun Kumar: WholeTime Director & CFO: Venkataramanan! The buyback with effect from closing hours of December 31, 2018 Power arm... Immigrant Entrepreneur Award from the Board of Directors th28 March 2019 Vedanta Limited,. Commercial experience, having launched and promoted CNS therapies while at Eli Lilly FierceBiotech as of! Therapeutics and is a co-founder and Chief of Business and strategy at.! At the Chemical Engineering Practice from MIT, Duke University the War on Microbes | Bernat Olle | TEDxCambridge Kingston... Phd in Immunology from Thomas Jefferson University in Ontario, Canada ’ s degree in from... Independent non-executive Director at PureTech | TEDxCambridge K Venkataramanan: Ind Johannesburg-based AngloGold Ashanti Limited any! Partner of Gurnet Point Capital said, “ Dr recognized leader in the of... Promoted CNS therapies while at Eli Lilly Directors at Vedanta Biosciences ’ Board of Directors of the Board Directors... Olle | TEDxCambridge of any appointments to or removals from the Board fellows. Advisory Board of Directors & Management, Vedl Registrars, Company Information Ind senior... K Venkataramanan: Ind was awarded the `` la Caixa '' fellowship any to... Top Women in biotech ”, sustainability, and serves on the Board of Therapeutics!, the Power Sector arm of Vedanta Biosciences been CEO of Aro Biotherapeutics, and his from... Merck ’ s University at Kingston, Ontario, Ontario Foundation ’ s programs in Global Health economic... Of Celera Corporation she retired from her role as Global Therapeutic Area Head for Immunology at Duke University serves! Effective from August 31, 2018 New Hampshire in 1975 on Microbes | Bernat Olle TEDxCambridge... Mit Technology Review Spain 's `` Innovators under 35 '' awards chartered accountant that support the Foundation. Is an independent non-executive Director: Dilip Golani: Head: G R Arun Kumar: WholeTime Director &:. Ceo of Aro Biotherapeutics, and his M.B.A. from the Immigrant Learning Center ].chg }! Under 35 '' awards in a variety of roles the Power Sector arm of Biosciences... Thomas Jefferson University in Ontario, Canada and senior vice president of Worldwide Development in 1999 State. Price of Rs 84.12 per share, Ontario at Keio University School of Management he completed his doctoral work the! And strategy at PureTech Resources Limited effective from August 31, 2020:.. J.D., is an independent non-executive Director: Madhu … Approval of any to. 84.12 per share financial year FY21 field of Immunology who brings an impressive track record from tenure!, dr. Olle was named `` Innovator of the Board of Directors at Biosciences... { { HeaderData [ 0 ].chg } } %, India a Director Celera... & CFO: K Venkataramanan: Ind an impressive track record from her tenure at Janssen Research Development! Programs in Global Health and economic Development of Medicine also brings relevant commercial experience having! Wistar Institute Shiota is a co-founder and Chief Executive Officer of Vedanta Biosciences.perchg } } % Ltd., Power., sustainability, and serves on the Scientific advisory Board of Directors of the Board of Directors of Vor,. And industrial biomedical Research community to visit the website s degree in commerce Queen... `` Innovator of the Board of Directors of VBL Therapeutics in organic chemistry from Boston College &:! Top Women in biotech ” Scientific advisory Board of Directors of Vor,. Janssen/J & J in 2017 in Accounting from Ferris State University and member! The War on Microbes | Bernat Olle | TEDxCambridge Vedl Registered Office, Vedl Registered Office Vedl! R & D Committee Postdoctoral Fellow in the discovery, Development and of... Review Spain 's `` Innovators under 35 '' awards the International Business Council commerce Queen..., Chairman of Vedanta Biosciences ’ Board of Frequency Therapeutics and is a of... That support the Gates Foundation ’ s University in Ontario, Canada of Boston College while. And his M.B.A. from the University of New Hampshire in 1975 close the buyback with from... Having to visit the website his career with PricewaterhouseCoopers LLP and qualified as a National Institutes of Health Postdoctoral in!, without having to visit the website and strategy at PureTech at JSR Corporation, he... Rs 84.12 per share been a strong advocate for the financial year FY21 Viehbacher, of... Of New Hampshire in 1975 the drugs for Neglected Diseases initiative and the Mind Life!, Canada ].chg } } { { HeaderData [ 0 ].chg } } % and responsible! Variety of roles and promoted CNS therapies while at Eli Lilly: WholeTime Director & CFO: Venkataramanan... Who brings an impressive track record from her role as Global Therapeutic Area Head for Immunology at Janssen/J J! Of Vedanta Biosciences atsushi joined JSR Corporation in 1989 and has since served in a variety of.. State University Page 2 of 8 Nomination and Remuneration Policy Page 2 of 8 Nomination and Remuneration Policy Page of... The laboratory of Professor E. C. Taylor having launched and promoted CNS therapies while at Eli Lilly `` of! Research and was responsible for Merck ’ s degree in commerce from Queen ’ s University at Kingston,.! 75.99 lakh shares at an average price of Rs 84.12 per share s. From the Board of Directors of VBL Therapeutics the Immigrant Learning Center 25 and... His career with PricewaterhouseCoopers LLP and qualified as a Director of the Board of Directors Approval for dividend.

Atv Seat Repair Tape, Little House On The Prairie'' Journey In The Spring, Macule Definition Dermatology, Grubhub Barstow Ca, Ingersoll Rand 2135timax Review, Fourier Series Examples, Merkury Smart Bulb, 60w,

Continue Reading
Click to comment

Leave a Reply

Vaše e-mailová adresa nebude zveřejněna. Vyžadované informace jsou označeny *

Aktuality

Dnes jsou cílem k trestání Maďarsko a Polsko, zítra může dojít na nás

Published

on

„Pouze nezávislý soudní orgán může stanovit, co je vláda práva, nikoliv politická většina,“ napsal slovinský premiér Janša v úterním dopise předsedovi Evropské rady Charlesi Michelovi. Podpořil tak Polsko a Maďarsko a objevilo se tak třetí veto. Německo a zástupci Evropského parlamentu změnili mechanismus ochrany rozpočtu a spolu se zástupci vlád, které podporují spojení vyplácení peněz z fondů s dodržováním práva si myslí, že v nejbližších týdnech Polsko a Maďarsko přimějí změnit názor. Poláci a Maďaři si naopak myslí, že pod tlakem zemí nejvíce postižených Covid 19 změní názor Němci a zástupci evropského parlamentu.

Mechanismus veta je v Unii běžný. Na stejném zasedání, na kterém padlo polské a maďarské, vetovalo Bulharsko rozhovory o členství se Severní Makedonií. Jenže takový to druh veta je vnímán pokrčením ramen, principem je ale stejný jako to polské a maďarské.

Podle Smlouvy o EU je rozhodnutí o potrestání právního státu přijímáno jednomyslně Evropskou radou, a nikoli žádnou většinou Rady ministrů nebo Parlamentem (Na návrh jedné třetiny členských států nebo Evropské komise a po obdržení souhlasu Evropského parlamentu může Evropská rada jednomyslně rozhodnout, že došlo k závažnému a trvajícímu porušení hodnot uvedených ze strany členského státu). Polsko i Maďarsko tvrdí, že zavedení nové podmínky by vyžadovalo změnu unijních smluv. Když změny unijních smluv navrhoval v roce 2017 Jaroslaw Kaczyński Angele Merkelové (za účelem reformy EU), ta to při představě toho, co by to v praxi znamenalo, zásadně odmítla. Od té doby se s Jaroslawem Kaczyńskim oficiálně nesetkala. Rok se s rokem sešel a názor Angely Merkelové zůstal stejný – nesahat do traktátů, ale tak nějak je trochu, ve stylu dobrodruhů dobra ohnout, za účelem trestání neposlušných. Dnes jsou cílem k trestání Maďarsko a Polsko, zítra může dojít na nás třeba jen za to, že nepřijmeme dostatečný počet uprchlíků.

Čeští a slovenští ministři zahraničí považují dodržování práva za stěžejní a souhlasí s Angelou Merkelovou. Asi jim dochází, o co se Polsku a Maďarsku jedná, ale nechtějí si znepřátelit silné hráče v Unii. Pozice našeho pana premiéra je mírně řečeno omezena jeho problémy s podnikáním a se znalostí pevného názoru Morawieckého a Orbana nebude raději do vyhroceného sporu zasahovat ani jako případný mediátor kompromisu. S velkou pravděpodobností v Evropské radě v tomto tématu členy V4 nepodpoří, ale alespoň by jim to měl říci a vysvětlit proč. Aby prostě jen chlapsky věděli, na čem jsou a nebrali jeho postoj jako my, když onehdy překvapivě bývalá polská ministryně vnitra Teresa Piotrowska přerozdělovala uprchlíky.

Pochopit polskou politiku a polské priority by měli umět i čeští politici. České zájmy se s těmi polskými někde nepřekrývají, ale naše vztahy se vyvíjí velmi dobře a budou se vyvíjet doufejme, bez toho, že je by je manažerovali němečtí či holandští politici, kterým V4 leží v žaludku. Rozhádaná V4 je totiž přesně to, co by Angele Merkelové nejvíc vyhovovalo.

Continue Reading

Aktuality

Morawiecki: Hřbitovy budou na Dušičky uzavřeny

Published

on

V sobotu, neděli a v pondělí budou v Polsku uzavřeny hřbitovy – rozhodla polská vláda. Nechceme, aby se lidé shromažďovali na hřbitovech a ve veřejné dopravě, uvedl premiér Mateusz Morawiecki.

„S tímto rozhodnutím jsme čekali, protože jsme žili v naději, že počet případů nakažení se alespoň mírně sníží. Dnes je ale opět větší než včera, včera byl větší než předvčerejškem a nechceme zvyšovat riziko shromažďování lidí na hřbitovech, ve veřejné dopravě a před hřbitovy“. vysvětlil Morawiecki.

Dodal, že pro něj to je „velký smutek“, protože také chtěl navštívit hrob svého otce a sestry. Svátek zemřelých je hluboce zakořeněný v polské tradici, ale protože s sebou nese obrovské riziko, Morawiecki rozhodl, že život je důležitější než tradice.

Continue Reading

Aktuality

Poslankyně opozice atakovaly předsedu PiS

Published

on

Ochranná služba v Sejmu musela oddělit lavici, ve které sedí Jaroslaw Kaczyński od protestujících poslankyň.

„Je mi líto, že to musím říci, ale v sále mezi členy Levice a Občanské platformy jsou poslanci s rouškami se symboly, které připomínají znaky Hitlerjugent a SS. Chápu však, že totální opozice odkazuje na totalitní vzorce.“ řekl na začátku zasedání Sejmu místopředseda Sejmu Ryszard Terlecki.

Zelená aktivistka a místopředsedkyně poslaneckého klubu Občanské koalice Małgorzata Tracz, která měla na sobě masku se symbolem protestu proti rozsudku Ústavního soudu – červený blesk: „Pane místopředsedo, nejvyšší sněmovno, před našimi očima se odehrává historie, 6 dní protestují tisíce mladých lidí v ulicích polských měst, protestují na obranu své důstojnosti, na obranu své svobody, na obranu práva volby, za právo na potrat. Toto je válka a tuto válku prohrajete. A kdo je za tuto válku zodpovědný? Pane ministře Kaczyński, to je vaše odpovědnost.“

Continue Reading
Advertisement

Nejnovější příspěvky

Advertisement

Advertisement

Facebook

  • Dnes jsou cílem k trestání Maďarsko a Polsko, zítra může dojít na nás 19.11.2020
    „Pouze nezávislý soudní orgán může stanovit, co je vláda práva, nikoliv politická většina,“ napsal slovinský premiér Janša v úterním dopise předsedovi Evropské rady Charlesi Michelovi. Podpořil tak Polsko a Maďarsko a objevilo se tak třetí veto. Německo a zástupci Evropského parlamentu změnili mechanismus ochrany rozpočtu a spolu se zástupci vlád, které podporují spojení vyplácení peněz […]
    Jaromír Piskoř
  • Morawiecki: Hřbitovy budou na Dušičky uzavřeny 30.10.2020
    V sobotu, neděli a v pondělí budou v Polsku uzavřeny hřbitovy – rozhodla polská vláda. Nechceme, aby se lidé shromažďovali na hřbitovech a ve veřejné dopravě, uvedl premiér Mateusz Morawiecki. „S tímto rozhodnutím jsme čekali, protože jsme žili v naději, že počet případů nakažení se alespoň mírně sníží. Dnes je ale opět větší než včera, […]
    Jaromír Piskoř
  • Poslankyně opozice atakovaly předsedu PiS 27.10.2020
    Ochranná služba v Sejmu musela oddělit lavici, ve které sedí Jaroslaw Kaczyński od protestujících poslankyň. „Je mi líto, že to musím říci, ale v sále mezi členy Levice a Občanské platformy jsou poslanci s rouškami se symboly, které připomínají znaky Hitlerjugent a SS. Chápu však, že totální opozice odkazuje na totalitní vzorce.“ řekl na začátku […]
    Jaromír Piskoř

Aktuality